In the latest trading session, 3.43 million Lipella Pharmaceuticals Inc (NASDAQ:LIPO) shares changed hands as the company’s beta touched 0.35. With the company’s most recent per share price at $0.36 changed hands at -$0.07 or -15.75% at last look, the market valuation stands at $2.87M. LIPO’s current price is a discount, trading about -652.78% off its 52-week high of $2.71. When we look at Lipella Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 0.16 million shares, with the 3-month average coming to 3.32 million.
Lipella Pharmaceuticals Inc (NASDAQ:LIPO) trade information
Instantly LIPO was in red as seen in intraday trades today. With action -17.64%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -64.80%, with the 5-day performance at -17.64% in the red. However, in the 30-day time frame, Lipella Pharmaceuticals Inc (NASDAQ:LIPO) is -18.41% down. Looking at the short shares, we see there were 0.9 million shares sold at short interest cover period of 0.1 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The consensus price target for the stock as assigned by Wall Street analysts is 2, meaning bulls need an upside of 82.0% from its recent market value. According to analyst projections, LIPO’s forecast low is 2 with 2 as the target high. To hit the forecast high, the stock’s price needs a -455.56% plunge from its current level, while the stock would need to soar -455.56% for it to hit the projected low.
Lipella Pharmaceuticals Inc (LIPO) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -189.86%. The 2024 estimates are for Lipella Pharmaceuticals Inc earnings to increase by 28.57%.
LIPO Dividends
Lipella Pharmaceuticals Inc is expected to release its next quarterly earnings report on 2024-Aug-13.
Lipella Pharmaceuticals Inc (NASDAQ:LIPO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 35.49% of Lipella Pharmaceuticals Inc shares while 7.87% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 12.21%.
